Pharmaceutical Law Group focuses on providing legal advice to pharmaceutical, biotechnology, and medical device companies on matters at the intersection of FDA regulation and intellectual property. Pharmaceutical law Group has extensive experience in advising companies on market protection strategies, data exclusivity, Orange Book listings and other Hatch-Waxman Act procedures, patent term restoration, competition from ANDA and 505(b)(2) applicants, pediatric exclusivity, orphan drug exclusivity, follow-on biologics, and similar matters that arise in the contexts of transactions, licensing, and due diligence. www.pharmalawgrp.com
Study Groups are clusters of experts with similar progessional backgrounds, indsutry expertise, experience level, job function, geography, and other characteristics. These are the top Study Groups members of Pharmaceutical Law Group PC belong to.